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Magnetic nanoparticles (MNPs) are promising materials for various biomedical applications, including magnetic resonance imag-
ing, stem cell tracking, gene/drug delivery, and cancer treatment. To increase the effectiveness of MNPs, high capture efficiency 
and controlled uptake of the particles by cells is required. In this paper we report the cytotoxicity and cellular uptake into SPC-A1 
cells of oxidized glutathione (GSSG)-modified MNPs (GSSG@Fe3O4). Experimental findings indicated that GSSG@Fe3O4 were 
biocompatible, and could be efficiently taken up by SPC-A1 cells (up to 160 pg iron per cell). The internalized GSSG@Fe3O4 was 
retained in the cell cytoplasm for 6 generations. The uptake of GSSG@Fe3O4 into SPC-A1 cells was energy-, concentration- and 
time-dependent. Pinocytosis may be involved in the internalization process of GSSG@Fe3O4 into SPC-A1 cells, but this mecha-
nism remains to be elucidated. The controlled and efficient localization of GSSG@Fe3O4 into the cytosol and long intracellular 
retention provides theoretical and experimental insight into the biomedical applications for these molecules.  
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Magnetic nanoparticles (MNPs) can be used in a wide vari-
ety of biomedical applications, ranging from cell labeling, 
magnetic resonance imaging, and gene/drug delivery for 
cancer treatment [1–9]. The uptake of MNPs by living cells 
very much depends on the MNP coating. Surface modifica-
tion can improve the biocompatibility and enhance cell up-
take of MNPs [10–15]. MNPs coated with dextran, or its 
derivatives, have been frequently used in the context of la-
beling cells with a magnetic tag [16]. However, cell accu-
mulation of these particles is usually low in non-phagocytic 
cells, culminating in a low MR detection sensitivity. The 
application of MNPs is affected by the net amount that are 
internalized, and those that remain within the cells after 
initial endocytosis, followed by exocytosis and intracellular 
degradation [13]. The cellular uptake of MNPs, especially 
their intracellular retention, is clearly crucial to the above 
applications. We therefore synthesized GSSG@Fe3O4, since 
glutathione is found in all cells in the body making it a very 
compatible target for MNP technology. These MNPs were 
then evaluated for their cytotoxicity, cellular uptake and 
intracellular retention into SPC-A1 cells. 
Most of the promising MNP applications, especially MRI 
and stem cell tracking, require well-defined and controllable 
interactions between the MNPs and living cells [1–5,8]. 
Furthermore, cellular uptake and intracellular pathways are 
dependent on the MNPs and cell type [9,13,16], so it is cru-
cial to elucidate the uptake kinetics and cellular internaliza-
tion pathways for GSSG@Fe3O4. This study provides theo-
retical and experimental insight into the biomedical applica-
tions of GSSG@Fe3O4.  
1  Materials and methods 
1.1  Materials and equipment 
(1) Materials.  FeCl3·6H2O (Analytical Reagent, AR),  
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FeSO4·7H2O (AR), GSSG (AR), nuclear fast red, Prussian 
blue, glutaraldehyde solution, dimethyl sulfoxide (DMSO), 
MTT solution and LDH cytotoxicity assay kit were all pur-
chased from Sigma Aldrich (Shanghai, China). Colchicine 
and cytochalasin B were from Sino-American Biotec 
(Shanghai, China). SPC-A1 (human lung adenocarcinoma 
cell line) was purchased from the Cell Bank of the Chinese 
Academy of Sciences. DMEM culture medium (high glucose) 
and fetal calf serum were obtained from Hyclone (Shanghai, 
China). All other reagents were obtained from Shanghai 
Reagent Company. 
(2) Equipment.  The equipment used in this study in-
cluded transmission electron microscopes (TEM, Philips 
CM-120 for the observation of MNPs and Philips Tecnai 
20S-TWIN for the observation of cell samples), Fourier 
transform infrared spectrometer (FTIR, Bruker EQUINOX 
55FTIR), Multilabel Counter (Victor-3, Perkin Elmer, USA) 
and an inductively coupled plasma optical emission spec-
trometer (ICP-OES, ICAP-6300, Thermo Fisher, USA). 
1.2  Methods 
(1) Preparation of GSSG@Fe3O4.  MNPs were prepared by 
co-precipitation of ferric and ferrous salts in an alkaline 
solution [17]. In brief, FeCl3·6H2O (24.3 g) and FeSO4·7H2O 
(16.7 g) were first dissolved in 200 mL deionized water 
under a blanket of nitrogen gas and heated to 75°C. Then 
ammonia solution (45 mL, 25% (v/v)) was added dropwise 
to the mixture with vigorous stirring. After stirring for 30 min, 
the temperature was raised to 85°C and GSSG (0.2 g) was 
added to the mixture. After reacting for 1 h, the mixture was 
cooled down to ambient temperature. The product was re-
trieved using a magnet, washed 5 times with deionized wa-
ter and finally dispersed in water. 
(2) Characterization of GSSG@Fe3O4 nanoparticles.  
The morphology and size of the particles were observed and 
analyzed by TEM. To do this, the particle suspension was 
directly deposited onto a carbon-coated copper grid and 
air-dried at room temperature. The particle size and size 
distribution were calculated using an image analysis soft-
ware of Image J by measuring the diameter of at least 300 
particles. The obtained particles were dissolved in deionized 
water and analyzed by FTIR. 
(3) Cytotoxic evaluation of GSSG@Fe3O4.  SPC-A1 
cells were cultured in DMEM medium, supplemented with 
10% fetal calf serum at 37°C in a 95:5 air/CO2 water-satu-     
rated atmosphere. Cell viability was investigated with MTT 
and LDH assays. For MTT assay, cells were seeded in 
96-well plates (1×105 cells/well) and incubated with culture 
medium containing GSSG@Fe3O4 at iron concentrations of 
0.6, 1.0 or 1.5 mg/mL for different periods of time (6, 12, 24 
or 48 h). After incubation, 20 L of MTT solution (5 mg/mL 
in PBS) was added to each well and incubated for 4 h. Then, 
the MTT containing medium was removed and 150 L 
DMSO was added to dissolve the formazan crystals pro-
duced from the reduction of MTT by viable cells. The opti-
cal density was measured at 570 nm using a Multilabel 
Counter. The cell viability was calculated using the following 
equation: cell viability=ODexperiment/ODcontrol×100%. For the 
LDH assay, after co-culturing with GSSG@Fe3O4 (0.6, 1.0 
or 1.5 mg Fe/mL) for 24, 48 or 72 h, the supernatant was 
analyzed with a LDH cytotoxicity assay kit according to the 
manufacturer’s protocol. SPC-A1 cells incubated with nano-
particle-free medium served as controls (100% cell viability). 
(4) Intracellular retention of GSSG@Fe3O4.  The intra-
cellular retention of GSSG@Fe3O4 was evaluated by TEM 
observation. SPC-A1 cells were washed twice after a 24 h 
incubation period in culture medium containing 1.0 mg/mL 
GSSG@Fe3O4, and cultured in fresh medium up to the 6th 
subpassage. Culture medium was changed every third day. 
After incubation, the culture medium was removed. The 
adhered cells of the 2nd, 4th or 6th generations were washed 
three times with PBS and harvested by trypsinization. The 
cells were centrifuged and redispersed into 4% (w/v) glutar-
aldehyde and processed for analysis by TEM using previ-
ously published methods [18]. 
(5) Uptake kinetics of GSSG@Fe3O4 by SPC-A1 cells. 
To evaluate the effects of temperature on cellular uptake, 
SPC-A1 cells were incubated with culture medium contain-
ing 0.2 mg/mL GSSG@Fe3O4 at 4°C for 24 h, or at 37°C 
for 1 h. After incubation, the culture medium was removed. 
The adhered cells were washed three times with PBS, har-
vested by trypsinization, fixed and processed for TEM 
analysis. 
To evaluate the effects of time and dose on cellular up-
take, intracellular iron uptake was quantitatively analyzed 
using ICP-OES and qualitatively analyzed by Prussian blue 
iron stain assays. For quantitative analysis, SPC-A1 cells 
were incubated with a culture medium containing GSSG@-    
Fe3O4 at the concentrations of 0.1, 0.4, 0.7 or 1.0 mg Fe/mL 
at 37°C for different periods of time (3, 6, 12, 24, 48 or 72 h). 
After incubation, the culture medium was removed. The 
adhered cells were washed, harvested, and digested with 
aqua regia, and then diluted to 10 mL. The iron content in 
cells was determined by ICP-OES. The iron content was 
expressed in picogram (pg) of Fe per cell.  
For qualitative analysis, SPC-A1 cells were incubated with 
GSSG@Fe3O4 at the same iron concentration (0.4 mg/mL) 
for 6 h, 24 h or co-cultured for the same time period (24 h) 
at an iron concentration of 0.1 or 1.0 mg/mL. After incuba-
tion, adhered cells were washed and observed by Prussian 
blue staining. For Prussian blue staining, the collected cells 
were fixed with methanol for 5 min, then acetone for 1 min, 
under 20°C and then air dried for 15 min. Slides were 
soaked in PBS for 5 min, and then incubated with 10% Prus-
sian blue [K4Fe(CN)6·3H2O] for 5 min. Subsequently, slides 
were further incubated with a mixture of 10% Prussian blue 
and 20% HCl (1:1) for 30 min, water for 10 min and finally 
nuclear fast red (Sigma Aldrich) for 10 min. Slides were 
then washed with water, 70%, 80%, 100% ethanol (twice) 
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and subsequently xylene. The slides were coverslipped with 
Vitro Clud coverslipping medium in preparation for mi-
croscopy. 
(6) Internalization pathway of GSSG@Fe3O4 in SPC-A1 
cells.  To investigate the possible pathway of cellular inter-
nalization of GSSG@Fe3O4, SPC-A1 cells were pretreated 
with 50 g/mL colchicine (an inhibitor of pinocytosis) or 50 
g/mL cytochalasin B (an inhibitor of phagocytosis) [19,20] 
for 4 h at 37°C. After incubation, the pretreatment solution 
was removed and the cells were washed with PBS. Cells 
were then co-cultured with 0.2 mg/mL GSSG@Fe3O4 for  
24 h. The intracellular iron was measured by ICP-OES and 
the cellular uptake of GSSG@Fe3O4 was observed by TEM. 
Statistical analyses were performed using SPSS 13.0 soft-
ware. The results were presented as the mean±SD and com-
pared using Student’s t-test. P < 0.05 was considered signif-
icant. To further investigate the uptake pathway of GSSG@-    
Fe3O4, TEM assays were performed. SPC-A1 cells were 
incubated in medium containing 1.0 mg/mL GSSG@Fe3O4 
for 1, 3 or 6 h. After incubation, the cells were washed, col-
lected, fixed and processed for analysis by TEM. 
2  Results and discussion 
2.1  Characterization of GSSG@Fe3O4 nanoparticles 
GSSG@Fe3O4 were well dispersed and the visualized di-
ameters were roughly 7–15 nm (Figure 1). FTIR spectra of 
GSSG@Fe3O4 and uncoated MNPs are shown in Figure 1. 
The FTIR spectra of GSSG@Fe3O4 exhibited characteristic 
absorption bands of an amido bond at 1640 cm1 due to the 
VC=O stretching vibration, which meant when GSSG was 
binding to iron ions found on the MNPs. The amido bonds 
were not involved in the reaction and the carboxyl groups of 
GSSG were probably chelated on the surface of MNPs. The 
NH bending vibration at 1550 cm1 and VCN stretching vi-
bration at 1405 cm1 were observed in GSSG@Fe3O4, but 
not observed in naked MNPs, indicating that MNPs were 
successfully coated with GSSG.  
2.2  Cytotoxic evaluation of GSSG@Fe3O4 
As shown in Figure 2(a), after incubation with GSSG@-    
Fe3O4, cell viability was similar to the control cells cultured 
with GSSG@Fe3O4-free medium. Even when cells were 
co-cultured with medium containing GSSG@Fe3O4 at 1.5 
mg/mL for 48 h, cell viability was still more than 90% 
(Figure 2(a)). LDH cytotoxicity assays were performed after 
co-culture with different concentrations of GSSG@Fe3O4 
for different periods of time. LDH release from SPC-A1 
cells was not obviously different compared with the control 
(Figure 2(b)). These results demonstrated that GSSG@Fe3O4 
did not cause severe cytotoxicity under the current conditions. 
Unmodified MNPs have been shown to cause cytotoxi-
city above a certain concentration [10]. This cytotoxicity 
has been shown to increase in a concentration dependent 
manner [21]. Although the MNPs were coated with bio-
compatible molecules, such as dextran, to reduce cytotoxi-
city [22], the reported concentrations of MNPs in culture 
medium shown to cause cytotoxicity were seldom more 
than 1 mg/mL. 
2.3  Intracellular retention of GSSG@Fe3O4 
After incubation with culture medium containing 1.0 mg/mL 
GSSG@Fe3O4 for 24 h, SPC-A1 cells were cultured in cul-
ture medium free of GSSG@Fe3O4 for up to the six genera-
tions. As shown in Figure 3(a), many nanoparticles in the 
cytoplasm of the 2nd generation SPC-A1 cells could be 
observed using TEM. Intracellular nanoparticles reduced in  
 
Figure 1  (a) TEM image of GSSG@Fe3O4 (scale bar=20 nm) and (b) IR spectra of GSSG@Fe3O4 (1) and uncoated MNPs (2). 
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Figure 2  Cytotoxic evaluation of GSSG@Fe3O4. SPC-A1 cells were incubated with culture medium containing GSSG@Fe3O4 at various iron concentra-
tions for different periods of time. Subsequently, cell survival and LDH activities were determined by MTT (a) and LDH assays (b) (mean±SD, n=3). 
SPC-A1 cells incubated with GSSG@Fe3O4-free medium served as controls (blank, 100% cell viability).  
 
Figure 3  TEM images of sub-cultured cells after co-culture with GSSG@Fe3O4. The 2nd (a), the 4th (b) and the 6th (c) generation of SPC-A1 cells after 
co-culture with GSSG@Fe3O4. Arrows show GSSG@Fe3O4 located in the cytoplasm. Scale bar=1 m. 
number from generation to generation, but remained visible 
until the 6th subpassage (Figure 3(c)). After the 6th genera-
tion nanoparticles were hardly observed in the cytoplasm as 
GSSG@Fe3O4 may be distributed to subpassaged cells via 
mitosis and eliminated via exocytosis.  
Cytotoxicity and intracellular retention assays demon-
strated that at a certain concentration range (0–1.5 mg/mL), 
GSSG@Fe3O4 had no obvious cytotoxic effects on SPC-A1 
cells, and that internalized GSSG@Fe3O4 could remain in 
SPC-A1 cells following several generations. These results 
imply the potential applied value of GSSG@Fe3O4 to cell 
tracking, MRI and intracellular hyperthermia. 
2.4  Uptake kinetics of GSSG@Fe3O4 into SPC-A1 cells  
GSSG@Fe3O4 absorbed to the cell membrane after co-culture 
with SPC-A1 cells at 4°C for 1 h. After culture for 24 h, 
there were no nanoparticles observed in the cytoplasm 
(Figure 4(a)). When SPC-A1 cells were co-cultured with 
GSSG@Fe3O4 at 37°C for 1 h, nanoparticles were observed 
in the cytoplasm (Figure 4(b)). As endocytosis is inhibited 
at low temperatures, these findings indicate that the endo-
cytosis of GSSG@Fe3O4 was an energy-dependent and ac-
tive process [23]. 
Both the results of iron content measurement assays and 
Prussian blue iron stain assays showed intracellular iron 
content was increased in a time and concentration depend-
ent manner in SPC-A1 cells (Figure 5), which is in accord-
ance with previous reports [12,18,24]. When co-cultured for 
48 h at 1.0 mg/mL of GSSG@Fe3O4, the iron content 
reached a plateau of 160 pg iron per cell (Figure 5A), sug-
gesting the uptake of GSSG@Fe3O4 was a saturable process 
[23].  
Cell labeling with MNPs is an increasingly common 
method for in vitro cell separation as well as for in vivo im-
aging. Magnetic cell labeling also raises very promising 
developments for therapy by allowing magnetic intracellular 
hyperthermia. All these applications require that cells con-
sistently and efficiently capture MNPs [21,23]. Our results 
demonstrated that the uptake of GSSG@Fe3O4 by SPC-A1 
cells was efficient and occurred in a concentration and time- 
dependent manner, which is crucial for their use in the 
above-mentioned biomedical applications.  
2.5  Internalization pathway of GSSG@Fe3O4 in SPC- 
A1 cells 
Historically, endocytic machinery has been classified into  
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Figure 4  Temperature-dependent uptake of GSSG@Fe3O4 by SPC-A1 cells. (a) Co-cultured SPC-A1 cells with 0.2 mg/mL GSSG@Fe3O4 at 4°C for 24 h; 
(b) co-cultured SPC-A1 cells with 0.2 mg/mL GSSG@Fe3O4 at 37°C for 1 h. Scale bar=1 m. 
 
Figure 5  Time and concentration-dependent uptake of GSSG@Fe3O4 by SPC-A1 cells. A. Quantitative analysis of intracellular iron uptake by ICP-OES. 
Co-cultured SPC-A1 cells with GSSG@Fe3O4 at an iron concentration of 0.1, 0.4, 0.7 or 1.0 mg/mL for different periods of time (3, 6, 12, 24, 48 or 72 h), 
respectively. B. Qualitative analysis of iron uptake by Prussian blue iron stain essays (200×). Co-cultured SPC-A1 cells with GSSG@Fe3O4 at different iron 
concentration for different time periods: (a) 0.4 mg/mL for 6 h; (b) 0.4 mg/mL for 24 h; (c) 0.1 mg/mL for 24 h; (d) 1.0 mg/mL for 24 h. Scale bar=50 m. 
phagocytotic and pinocytotic [25]. Specifically, the pinocy-
totic pathway and phagocytotic pathway are inhibited by 
colchicine and cytochalasin B pretreatments, respectively 
[19,20]. We examined the impact of these inhibitors on these 
endocytotic pathways and noted the cellular uptake. The 
results are presented in Figure 6.  
As shown in Figure 6, the amount of iron in SPC-A1 
cells (18.7±1.9 pg) was apparently reduced compared with 
the control (82.6±5 pg) when pretreated with colchicine 
(P<0.05), but this reduction did not occur with the treatment 
of cytochalasin B (69.3±6.5 pg). These observations were in 
agreement with TEM observations (Figure 6B). Internalized 
GSSG@Fe3O4 in the cytoplasm of SPC-A1 cells was great-
er in cells treated with cytochalasin B compared with col-
chicine. Colchicine, known as a functional inhibitor of mi-
crotubule assembly that causes microtubule disruption, pre-
vented nanoparticle uptake by inhibiting the pinocytotic 
pathway. These results suggest that pinocytosis appears to 
be the internalization pathway for GSSG@Fe3O4 in SPC-A1 
cells. 
TEM was then used to visualize the uptake process of 
GSSG@Fe3O4 and the intracellular compartmentalization in 
SPC-A1 cells. After co-culture of the SPC-A1 cells with 
GSSG@Fe3O4, the uptake process of nanoparticles from 
coated pits (Figure 7(a), black arrows) to endosomes (Fig-
ure 7(a), white arrows) and then lysosomes (Figure 7(c),(d)) 
was observed. We believe Figure 7(b) depicts the amalgam-
ation process of endosomes (white arrow) and lysosomes 
(black arrow).  
Previous reports [12,23,26] and inhibition assays lead us  
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Figure 6  The effects of inhibitors on iron uptake. A, Iron uptake after cells were treated with inhibitors was determined by ICP-OES assays (mean±SD, 
n=3); B, TEM images of GSSG@Fe3O4 uptake by SPC-A1 cells after treatment with inhibitors ((a) control; (b) cytochalasin B; (c) colchicine). Scale bar=1 
m. SPC-A1 cells incubated with inhibitor-free medium served as controls.  
 
Figure 7  TEM images of the GSSG@Fe3O4 uptake process into SPC-A1 cells. After co-culture of SPC-A1 cells with GSSG@Fe3O4 for 1 h, GSSG@Fe3O4 
entered the coated pits ((a) black arrows) and endosomes ((a) white arrows). After 3 h, the amalgamation process of the endosome ((b) white arrow) and the 
lysosome ((b) black arrow) was observed. After 6 h, many lysosomes contained entrapped GSSG@Fe3O4 ((c), (d) black arrows). Scale bar=1 m. 
to believe that these TEM images may show the process of 
pinocytosis, but further research is required for clear eluci-
dation of this process. As in our previous research on uptake 
mechanisms, phagocytosis, instead of pinocytosis, may be 
involved in the internalization process of aminosilane-coated 
MNPs into SPC-A1 cells [26]. Our results showed the 
mechanism of endocytosis was dependent on the surface 
modification of nanoparticles. 
3  Conclusions 
In summary, GSSG@Fe3O4 showed high biocompatibility 
and high capture efficiency (up to 160 pg iron per cell) in 
SPC-A1 cells. Furthermore, GSSG@Fe3O4 nanoparticles 
were retained in the cytoplasm of SPC-A1 for six genera-
tions. The uptake of GSSG@Fe3O4 into SPC-A1 cells was 
energy, concentration and time-dependent. Pinocytosis might 
be involved in the internalization process of GSSG@Fe3O4, 
but remains to be elucidated. 
The safe and efficient localization of GSSG@Fe3O4 to 
the cytoplasm may be critical in applications such as MRI, 
drug delivery systems for lung cancer therapy and intracel-
lular hyperthermia. This study provides theoretical and ex-
perimental insight into the biomedical applications of 
GSSG@Fe3O4.  
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